The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Polio, a disease that can cause lifelong paralysis, has been eliminated from the U.S. Experts fear a resurgence if lifesaving ...

The vaccine triggered a satisfactory immune response against the pathogen in ... "Most vaccines are based on attenuated or inactivated viruses, but our next-generation strategy enables us to ...

The use of adjuvants with immunopotentiating properties that can direct the immune responses to humoral ... pathogenic than the real pathogen; inactivated vaccines that are heat-inactivated ...

Results provide clinical demonstration of best-in-class immunogenicity achieved with an RNA-based platform and good tolerability RBI-4000's ...

They included a total of 135 adults who were vaccinated with inactivated ... performed to evaluate immune responses in different age groups at various timepoints of vaccination.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, alongside other influenza vaccines, health officials ...